CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 656 enrolled
Drug / intervention
Quality of life measure (survey)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02439710
NCT02439710N/ACompleted

Patient Reported Outcomes Burdens and Experiences - Phase 2 - Pilot Feasibility Study

McMaster University·observational·Posted May 12, 2015·Updated Oct 31, 2019

In Brief

An observational study evaluating Quality of life measure (survey) for Hemophilia. Completed, enrolled 656 participants across 1 site.

Detailed Summary

The Patient Reported Outcomes, Burdens, and Experiences (PROBE) Study aims to develop a new global tool to enhance the direct patient-voice in health care decision-making. Government and private payers increasingly value data based on patient-centered outcomes research as part of the overall cost-benefit evaluation of high-cost care and treatment of diseases such as hemophilia. This emerging dimension of the healthcare environment presents a significant opportunity and urgent need to improve patient organizations' ability to collect and interpret relevant outcomes data. More robust patient reported data will improve advocacy efforts to build comprehensive care programs, promote home treatment and implement preventative treatment regimens thus allowing advocacy arguments to move beyond emotion and anecdote to those grounded in real-world patient experiences and evidence. With the support of the National Hemophilia Foundation, a global team of investigators will lead a patient focused research project to investigate and directly probe patient perspectives on outcomes they deem relevant to their care. Through PROBE, the investigators will develop and seek to validate the reliability, reproducibility and responsiveness of a low cost, easily administrable inventory for collecting patient self-reported outcomes, burdens and experiences in living with hemophilia. The investigators anticipate that the metrics established through PROBE will allow for comparison of patient outcomes within a country over time and cross-sectionally between countries (regionally and globally).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemophilia
CountriesCanada

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 12, 2015
Enrollment StartJun 1, 2015
Primary CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 11.1 years ago

Interventions

Quality of life measure (survey)other

The QoL tool is a questionnaire